FN1 and atherosclerosis: Research findings indicate that mice lacking the regulation of splicing by the EDA exon of fibronectin (FN) exhibit a 40% reduction in atherosclerotic lesions, which suggests that the regulated splicing of the EDA exon plays a crucial role in the progression of atherosclerosis [35].